FDA Clearance Tracker · P960009-S438
Master Activa®, Percept and SenSight Deep Brain Stimulation Therapy System
Last checked: Nov 20, 2026Latest source record: Jan 8, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jan 8, 2024
Approved
Time to decision
497 days
Received Aug 29, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P960009-S438
- Device name
- Master Activa®, Percept and SenSight Deep Brain Stimulation Therapy System
- Applicant
- Medtronic, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Aug 29, 2022
- Decided
- Jan 8, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P960009
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the following: For P960009/S438, approval for: Model B35300 Percept RC Implantable Neurostimulator (INS) Model RS6230 Recharger Kit (including the WR9230 Recharger) Model A610 Clinician Programmer Application (PPA) Software (Version 4.0) Model A620 Patient Programmer Application (CPA) (Version 3.0) A90300 Recharger Application Software (RAS) (Version 2.0) Labeling changes in physician and patient labeling for existing products, to be consistent with the proposed labeling for the new Percept RC System.For H020007/S329, approval for: Model B35300 Percept RC Implantable Neurostimulator (INS) Model RS6230 Recharger Kit (including the WR9230 Recharger) Model A610 Clinician Programmer Application (PPA) Software (Version 4.0) Model A620 Patient Programmer Application (CPA) (Version 3.0) A90300 Recharger Application Software (RAS) (Version 2.0) Dystonia Kits (Models 33TH60, 33TH76, and 33TH69) Labeling changes in physician and patient labeling for existing products, to be consistent with the proposed labeling for the new Percept RC System.For H050003/S289, approval for: Model A610 Clinician Programmer Application (PPA) Software (Version 4.0) For P840001/S527, approval for: Labeling changes in physician and patient labeling for existing products, to be consistent with the proposed labeling for the new Percept RC System
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.